Alcon Inc. ALC
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- -9.34%
- 1 year
- -3.78%
- Open
- 72.34
- Prev close
- 71.13
- Mkt cap
- 34.54B
- Vol
- 1.61M
- Avg vol
- 1.68M
- EPS
- 1.32
- P/E
- 54.13
- Div yield
- 0.51%
More statistics
- Low
- 71.27
- High
- 72.67
- Forward P/E
- 18.08
- Beta
- 0.73
- Short ratio
- 10.62
- Inst. own
- 62.56%
- Dividend
- 0.36
- Ex-div date
- May 5, 2026
- Earnings
- Nov 10, 2026
- 50-d avg
- 67.67
- 200-d avg
- 71.99
- 1y target
- 81.98
5D chart
Events in this range
- Oct 27, 2026Rating: Keybanc · Overweight → Overweight
Signals (153)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Oct 30, 3:55 PM | 2 days ago |
| SMA: Bearish | Oct 30, 3:55 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 3:55 PM | 2 days ago |
| SMA: Bullish | Oct 30, 3:50 PM | 2 days ago |
| SMA: Bullish | Oct 30, 3:50 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 3:50 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 3:45 PM | 2 days ago |
| SMA: Bearish | Oct 30, 3:35 PM | 2 days ago |
| SMA: Bullish | Oct 30, 3:30 PM | 2 days ago |
| SMA: Bearish | Oct 30, 3:25 PM | 2 days ago |
| SMA: Bullish | Oct 30, 3:20 PM | 2 days ago |
| SMA: Bullish | Oct 30, 3:20 PM | 2 days ago |
| SMA: Bearish | Oct 30, 3:15 PM | 2 days ago |
| SMA: Bearish | Oct 30, 3:15 PM | 2 days ago |
| SMA: Bearish | Oct 30, 2:40 PM | 2 days ago |
| SMA: Bullish | Oct 30, 2:35 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 2:35 PM | 2 days ago |
| SMA: Bullish | Oct 30, 2:30 PM | 2 days ago |
| SMA: Bearish | Oct 30, 1:05 PM | 2 days ago |
| SMA: Bullish | Oct 30, 1:00 PM | 2 days ago |
| SMA: Bearish | Oct 30, 12:50 PM | 2 days ago |
| SMA: Bearish | Oct 30, 12:50 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 12:50 PM | 2 days ago |
| SMA: Bullish | Oct 30, 12:45 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 12:45 PM | 2 days ago |
| SMA: Bearish | Oct 30, 12:40 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 12:40 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 12:30 PM | 2 days ago |
| SMA: Bullish | Oct 30, 12:25 PM | 2 days ago |
| SMA: Bullish | Oct 30, 12:25 PM | 2 days ago |
| SMA: Bearish | Oct 30, 12:20 PM | 2 days ago |
| SMA: Bullish | Oct 30, 11:55 AM | 2 days ago |
| SMA: Bearish | Oct 30, 11:50 AM | 2 days ago |
| SMA: Bullish | Oct 30, 11:25 AM | 2 days ago |
| SMA: Bearish | Oct 30, 11:20 AM | 2 days ago |
| SMA: Bullish | Oct 30, 11:15 AM | 2 days ago |
| SMA: Bearish | Oct 30, 11:05 AM | 2 days ago |
| MACD: Sell Signal | Oct 30, 10:25 AM | 2 days ago |
| SMA: Bearish | Oct 30, 10:05 AM | 2 days ago |
| RSI: Overbought | Oct 30, 9:30 AM | 2 days ago |
| MACD: Buy Signal | Oct 29, 3:30 PM | 3 days ago |
| SMA: Bullish | Oct 29, 3:25 PM | 3 days ago |
| SMA: Bearish | Oct 29, 3:05 PM | 3 days ago |
| SMA: Bullish | Oct 29, 3:00 PM | 3 days ago |
| SMA: Bullish | Oct 29, 3:00 PM | 3 days ago |
| SMA: Bearish | Oct 29, 2:25 PM | 3 days ago |
| SMA: Bullish | Oct 29, 2:05 PM | 3 days ago |
| SMA: Bearish | Oct 29, 1:10 PM | 3 days ago |
| SMA: Bearish | Oct 29, 1:10 PM | 3 days ago |
| SMA: Bullish | Oct 29, 1:00 PM | 3 days ago |
| SMA: Bullish | Oct 29, 1:00 PM | 3 days ago |
| SMA: Bearish | Oct 29, 12:50 PM | 3 days ago |
| SMA: Bearish | Oct 29, 12:50 PM | 3 days ago |
| SMA: Bullish | Oct 29, 12:10 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 11:35 AM | 3 days ago |
| SMA: Bearish | Oct 29, 11:30 AM | 3 days ago |
| RSI: Overbought | Oct 29, 10:45 AM | 3 days ago |
| SMA: Bullish | Oct 29, 10:35 AM | 3 days ago |
| MACD: Buy Signal | Oct 29, 10:35 AM | 3 days ago |
| MACD: Sell Signal | Oct 29, 10:30 AM | 3 days ago |
| SMA: Bearish | Oct 29, 10:15 AM | 3 days ago |
| RSI: Overbought | Oct 29, 9:45 AM | 3 days ago |
| RSI: Overbought | Oct 29, 9:30 AM | 3 days ago |
| SMA: Bullish | Oct 28, 3:55 PM | 4 days ago |
| SMA: Bearish | Oct 28, 3:50 PM | 4 days ago |
| SMA: Bullish | Oct 28, 3:45 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 3:45 PM | 4 days ago |
| SMA: Bearish | Oct 28, 3:35 PM | 4 days ago |
| SMA: Bullish | Oct 28, 3:30 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:50 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:40 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 2:40 PM | 4 days ago |
| SMA: Bullish | Oct 28, 2:35 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 2:35 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 2:30 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:15 PM | 4 days ago |
| SMA: Bullish | Oct 28, 1:25 PM | 4 days ago |
| SMA: Bearish | Oct 28, 12:55 PM | 4 days ago |
| SMA: Bullish | Oct 28, 12:50 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 12:50 PM | 4 days ago |
| SMA: Bullish | Oct 28, 12:40 PM | 4 days ago |
| SMA: Bearish | Oct 28, 11:35 AM | 4 days ago |
| SMA: Bearish | Oct 28, 11:35 AM | 4 days ago |
| SMA: Bullish | Oct 28, 11:15 AM | 4 days ago |
| MACD: Sell Signal | Oct 28, 10:40 AM | 4 days ago |
| SMA: Bearish | Oct 28, 10:20 AM | 4 days ago |
| RSI: Overbought | Oct 28, 10:00 AM | 4 days ago |
| RSI: Overbought | Oct 28, 9:45 AM | 4 days ago |
| MACD: Buy Signal | Oct 28, 9:40 AM | 4 days ago |
| SMA: Bullish | Oct 28, 9:35 AM | 4 days ago |
| SMA: Bullish | Oct 28, 9:35 AM | 4 days ago |
| MACD: Sell Signal | Oct 28, 9:30 AM | 4 days ago |
| SMA: Bearish | Oct 27, 3:50 PM | 5 days ago |
| SMA: Bullish | Oct 27, 3:10 PM | 5 days ago |
| SMA: Bearish | Oct 27, 2:50 PM | 5 days ago |
| SMA: Bullish | Oct 27, 2:45 PM | 5 days ago |
| SMA: Bullish | Oct 27, 2:45 PM | 5 days ago |
| SMA: Bearish | Oct 27, 2:35 PM | 5 days ago |
| SMA: Bearish | Oct 27, 2:35 PM | 5 days ago |
| SMA: Bullish | Oct 27, 2:25 PM | 5 days ago |
| SMA: Bearish | Oct 27, 2:15 PM | 5 days ago |
| SMA: Bullish | Oct 27, 2:10 PM | 5 days ago |
| SMA: Bullish | Oct 27, 1:30 PM | 5 days ago |
| SMA: Bearish | Oct 27, 1:25 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 1:20 PM | 5 days ago |
| SMA: Bullish | Oct 27, 1:15 PM | 5 days ago |
| RSI: Oversold | Oct 27, 1:05 PM | 5 days ago |
| SMA: Bearish | Oct 27, 12:05 PM | 5 days ago |
| SMA: Bearish | Oct 27, 12:05 PM | 5 days ago |
| SMA: Bullish | Oct 27, 12:00 PM | 5 days ago |
| SMA: Bullish | Oct 27, 12:00 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 11:30 AM | 5 days ago |
| SMA: Bearish | Oct 27, 11:25 AM | 5 days ago |
| SMA: Bullish | Oct 27, 11:20 AM | 5 days ago |
| SMA: Bearish | Oct 27, 11:10 AM | 5 days ago |
| SMA: Bearish | Oct 27, 11:10 AM | 5 days ago |
| SMA: Bullish | Oct 27, 11:00 AM | 5 days ago |
| SMA: Bearish | Oct 27, 10:55 AM | 5 days ago |
| SMA: Bullish | Oct 27, 10:30 AM | 5 days ago |
| MACD: Buy Signal | Oct 27, 10:30 AM | 5 days ago |
| SMA: Bearish | Oct 27, 10:20 AM | 5 days ago |
| SMA: Bullish | Oct 27, 10:10 AM | 5 days ago |
| SMA: Bearish | Oct 27, 9:30 AM | 5 days ago |
| SMA: Bearish | Oct 27, 9:30 AM | 5 days ago |
| MACD: Sell Signal | Oct 27, 9:30 AM | 5 days ago |
| RSI: Oversold | Oct 27, 9:30 AM | 5 days ago |
| SMA: Bullish | Oct 26, 3:45 PM | 6 days ago |
| SMA: Bearish | Oct 26, 3:40 PM | 6 days ago |
| SMA: Bullish | Oct 26, 3:20 PM | 6 days ago |
| SMA: Bullish | Oct 26, 3:05 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 3:05 PM | 6 days ago |
| SMA: Bearish | Oct 26, 2:50 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 2:50 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 2:40 PM | 6 days ago |
| SMA: Bearish | Oct 26, 2:35 PM | 6 days ago |
| SMA: Bullish | Oct 26, 2:25 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 1:50 PM | 6 days ago |
| SMA: Bearish | Oct 26, 1:40 PM | 6 days ago |
| SMA: Bearish | Oct 26, 1:40 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 1:20 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 1:05 PM | 6 days ago |
| SMA: Bearish | Oct 26, 12:45 PM | 6 days ago |
| SMA: Bearish | Oct 26, 12:45 PM | 6 days ago |
| SMA: Bullish | Oct 26, 12:35 PM | 6 days ago |
| SMA: Bullish | Oct 26, 12:35 PM | 6 days ago |
| SMA: Bearish | Oct 26, 12:30 PM | 6 days ago |
| SMA: Bearish | Oct 26, 12:25 PM | 6 days ago |
| SMA: Bullish | Oct 26, 12:00 PM | 6 days ago |
| SMA: Bearish | Oct 26, 11:50 AM | 6 days ago |
| SMA: Bullish | Oct 26, 11:30 AM | 6 days ago |
| SMA: Bearish | Oct 26, 10:35 AM | 6 days ago |
| SMA: Bullish | Oct 26, 10:30 AM | 6 days ago |
| SMA: Bearish | Oct 26, 10:25 AM | 6 days ago |
News
-
5 days ago benzinga.com
Keybanc Maintains Overweight on Alcon, Lowers Price Target to $84
Keybanc analyst Brett Fishbin maintains Alcon (NYSE:ALC) with a Overweight and lowers the price target from $88 to $84.
1 week ago seekingalpha.com
Alcon Sees Another Bullish Rating After Clear Portfolio Growth Direction In Eyecare
Alcon Inc. remains a Buy, supported by FDA approvals, portfolio-expanding acquisitions, and robust long-term eyecare demand despite recent market underperformance. ALC demonstrates steady revenue…
-
1 week ago benzinga.com
Alcon Acquires Neurotech Pharmaceuticals For $550M
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced it has acquired Neurotech Pharmaceuticals, Inc., a company focused on developing…
1 week ago businesswire.com
Alcon Acquires Neurotech and ENCELTO, the Only FDA-Approved Treatment for MacTel Type 2
GENEVA--(BUSINESS WIRE)--Alcon Acquires Neurotech and ENCELTO, the Only FDA Approved Treatment for MacTel Type 2.
1 week ago globenewswire.com
Algoma Central Corporation Announces $62.5 million Offering of 6.20% Convertible Unsecured Subordinated Debentures
CATHARINES, ONTARIO, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Algoma Central Corporation (“Algoma”) (TSX:ALC) announced today that it has entered into an agreement to sell, on a bought deal basis to a…
2 weeks ago businesswire.com
FDA Approves Alcon's BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes
GENEVA--(BUSINESS WIRE)--FDA Approves Alcon's BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes.
-
2 weeks ago benzinga.com
Alcon Announces FDA Approval For BRYTLY Redness Relief Eye Drops, Expanding Over The Counter Eye Care Portfolio.
One drop works to significantly reduce redness, with results lasting up to 12 hours1Lasts up to 50% longer than Lumify1-2,*Expands Alcon's portfolio of consumer eye care solutions and will be…
2 weeks ago businesswire.com
FDA Approves Alcon's BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes
GENEVA--(BUSINESS WIRE)--FDA Approves Alcon's BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes.
2 weeks ago zacks.com
Credo Expands AI Connectivity Portfolio With 1.6T ZeroFlap ALC
CRDO expands its AI connectivity portfolio with the 1.6T ZeroFlap Active Light Cable, offering lower power consumption, enhanced reliability and extended reach.
2 weeks ago gurufocus.com
Credo Unveils 1.6T ZeroFlap Active Light Cable, Industry's First Row-Scale, Wide-Parallel Optical Interconnect for AI Data Centers
[url="]Credo Technology Group Holding Ltd[/url] (Credo) (NASDAQ: CRDO), an innovator in providing connectivity at scale through fast, reliable, and energy-effic
-
3 weeks ago benzinga.com
Barclays Initiates Coverage On Alcon with Equal-Weight Rating, Announces Price Target of $70
Barclays analyst Christopher Pasquale initiates coverage on Alcon (NYSE:ALC) with a Equal-Weight rating and announces Price Target of $70.
3 weeks ago defenseworld.net
Algoma Central (TSE:ALC) Shares Cross Above 50 Day Moving Average – Here’s Why
Algoma Central Co. (TSE: ALC - Get Free Report) passed above its 50 day moving average during trading on Tuesday. The stock has a 50 day moving average of C$23.31 and traded as high as C$23.99.…
1 month ago zacks.com
Is it a Prudent Move to Retain ALC Stock in Your Portfolio Now?
Alcon's acquisitions, partnerships and new product launches support growth, but tariffs and intense competition remain key risks.
1 month ago seekingalpha.com
Alcon: A Re-Rating In Eyesight
Alcon is a structurally advantaged ophthalmology leader with a durable equipment-to-consumables model and strong recurring revenue streams. At $72, ALC trades at ~18x forward earnings, reflecting…
1 month ago businesswire.com
Alcon Launches UNITY M, a Premium Ophthalmic Microscope Delivering Precise Control
GENEVA--(BUSINESS WIRE)--Alcon Launches UNITY® M, a Premium Ophthalmic Microscope Delivering Precise Control.
2 months ago benzinga.com
Trump Expands Drug Pricing Deals With 9 Pharma Companies, Bringing Total to 26 — RFK Jr. Details 'Very, Very Emotional' Conversations With President
Trump secures drug pricing deals with nine pharma companies as Kennedy reveals intense pressure from the President to deliver.
2 months ago businesswire.com
Alcon Prices EUR 500 Million Senior Notes Offering
GENEVA--(BUSINESS WIRE)--Alcon Prices EUR 500 Million Senior Notes Offering.
2 months ago benzinga.com
Why Is Netflix Stock Falling on Monday?
Netflix Inc. (NASDAQ: NFLX) stock slips as market concerns over third-quarter revenue and earnings guidance outweigh Bill Ackman's new Pershing Square stake.
2 months ago seekingalpha.com
Alcon: A Strong Company Trading Close To Its Intrinsic Value, Buy
Alcon reported strong core operating profit (barring a one-time non-cash $402 million charge) during the quarter, up 17%. The company raised its full-year 2026 profit forecast for the second…
2 months ago fool.com
Bill Ackman Just Disclosed 6 New Positions, and 4 of Them Are Financial Stocks. Here's What He's Betting On.
The famous long-term investor and his team made notable changes to Pershing Square's equity portfolio.
2 months ago benzinga.com
Bill Ackman’s New Stock Picks Are Here. These ETFs Could Be Worth Watching
Bill Ackman's new stock picks include Netflix, Visa and Mastercard. ETF investors can get fresh exposure through VFH, XLC and IAI.
2 months ago gurufocus.com
Why Netflix Stock Popped Today
Bill Ackman (Trades, Portfolio)'s Pershing Square Capital Management has built a new position in Netflix (NFLX), returning to the streaming company after a cost
2 months ago gurufocus.com
Bill Ackman Buys Back Into Netflix Four Years After Selling at a Loss
Bill Ackman (Trades, Portfolio) disclosed six new holdings, buying Netflix (NFLX), Visa (V), Mastercard (MA), eye care company Alcon (ALC), exchange operator In
2 months ago benzinga.com
Bill Ackman Lost $400 Million on NFLX Stock in 2022 — Now He’s Back With a 3.15M-Share Bet, Saying Netflix Has ‘Won the Streaming Wars’ (UPDATED)
Bill Ackman’s Pershing Square re-enters Netflix with a 3.15M share stake, declaring the streaming wars won after a historic 2022 loss.
2 months ago 247wallst.com
Here Are Thursday’s Top Wall Street Analyst Research Calls: Abbott Labs, AbbVie, Akamai Technologies, Five Below, Keurig Dr. Pepper, Salesforce, Stryker, StubHub, and More
Wall Street analysts made bold moves Thursday, slashing targets on some names while dramatically upgrading others, and the gap between winners and losers tells a story about where smart money is…
-
2 months ago benzinga.com
JP Morgan Maintains Neutral on Alcon, Raises Price Target to $78.4
JP Morgan analyst David Adlington maintains Alcon (NYSE:ALC) with a Neutral and raises the price target from $77.53 to $78.4.
-
2 months ago benzinga.com
Mizuho Maintains Outperform on Alcon, Raises Price Target to $85
Mizuho analyst Anthony Petrone maintains Alcon (NYSE:ALC) with a Outperform and raises the price target from $80 to $85.
2 months ago benzinga.com
National CineMedia Posts Downbeat Q2 Results, Joins Borr Drilling, AbCellera Biologics And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session
U.S. stock futures higher, Nasdaq 100 up 150 pts. National CineMedia shares down 16.4% on weak Q2 results and Captivate Holdings acquisition. Other stocks also falling in pre-market trading.
2 months ago seekingalpha.com
Alcon Inc. (ALC) Q2 2026 Earnings Call Transcript
Alcon Inc. (ALC) Q2 2026 Earnings Call Transcript
2 months ago gurufocus.com
Alcon Stock Jumps 4% as Tariff Relief Lifts Profit Target
Alcon (ALC), a global eye-care powerhouse, raised its 2026 profitability outlookâand investors liked what they saw. The Swiss shares jumped roughly 4% Tuesday
2 months ago zacks.com
Alcon's Q2 Earnings and Revenues Surpass Estimates, Stock Climbs
ALC's Q2 earnings and sales beat estimates as equipment and ocular health gains lift results, while the company raises its 2026 EPS outlook.
2 months ago benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers P3 Health Partners (NASDAQ:PIII) shares increased by 24.1% to $15.92 during Monday's after-market session. The market value of their outstanding shares is at $38.5 million. As per the press…
-
2 months ago benzinga.com
Alcon Raises FY2026 Adj EPS Guidance from $3.38-$3.47 to $3.44-$3.53 vs $3.41 Est; Widens FY2026 Sales Guidance of $10.835B-$11.041B vs $11.087B Est
Alcon (NYSE:ALC) raises FY2026 Adj EPS guidance from $3.38-$3.47 to $3.44-$3.53 vs $3.41 analyst estimate. Widens FY2026 sales outlook from $10.835 billion-$11.041 billion to $10.835 billion-$11.041…
-
2 months ago benzinga.com
Alcon Q2 Adj. EPS $0.84 Beats $0.75 Estimate, Sales $2.782B Beat $2.769B Estimate
Alcon (NYSE:ALC) reported quarterly earnings of $0.84 per share which beat the analyst consensus estimate of $0.75 by 12 percent. This is a 10.53 percent increase over earnings of $0.76 per share…
2 months ago benzinga.com
S&P 500 Surges To Record Close Following Jobs Data: Investor Sentiment Improves, Fear Index Remains in ‘Greed’ Zone
U.S. stocks closed higher, with Nasdaq up 300 points. S&P 500 and Nasdaq rose for the second consecutive week. Fear & Greed index in Greed zone.
2 months ago benzinga.com
Aecom, Alcon And 3 Stocks To Watch Heading Into Monday
U.S. stock futures mixed, Aecom and Hawaiian Electric report earnings, Alcon expected to release earnings, Check Cap announces reverse split, Monday.Com expected to post earnings.
-
3 months ago benzinga.com
Mizuho Maintains Outperform on Alcon, Lowers Price Target to $80
Mizuho analyst Anthony Petrone maintains Alcon (NYSE:ALC) with a Outperform and lowers the price target from $85 to $80.
-
3 months ago benzinga.com
Alcon And RxSight Announce A Non-Exclusive Collaboration To Jointly Develop Adjustable Presbyopia-Correcting Intraocular Lenses
Alcon (NYSE:ALC), the global leader in eye care dedicated to helping people see brilliantly, and RxSight, Inc. (NASDAQ:RXST), an ophthalmic medical device company dedicated to providing high-quality…
5 months ago benzinga.com
Zoetis, Insmed, And HubSpot Are Among Top 10 Large-Cap Losers Last Week (May 4-May 8): Are The Others In Your Portfolio?
Weak earnings, soft guidance and analyst target cuts triggered sharp selloffs across healthcare, software, networking and industrial stocks last week, led by Zoetis, Insmed and HubSpot.
-
5 months ago benzinga.com
Barclays Maintains Equal-Weight on Alcon, Lowers Price Target to $78
Barclays analyst Matt Miksic maintains Alcon (NYSE:ALC) with a Equal-Weight and lowers the price target from $90 to $78.
-
5 months ago benzinga.com
Wells Fargo Maintains Overweight on Alcon, Lowers Price Target to $86
Wells Fargo analyst Larry Biegelsen maintains Alcon (NYSE:ALC) with a Overweight and lowers the price target from $97 to $86.
-
5 months ago benzinga.com
Mizuho Maintains Outperform on Alcon, Lowers Price Target to $85
Mizuho analyst Anthony Petrone maintains Alcon (NYSE:ALC) with a Outperform and lowers the price target from $95 to $85.
-
5 months ago benzinga.com
Baird Maintains Outperform on Alcon, Lowers Price Target to $90
Baird analyst Jeff Johnson maintains Alcon (NYSE:ALC) with a Outperform and lowers the price target from $98 to $90.
-
8 months ago benzinga.com
This US Bancorp Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday
This US Bancorp Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday
8 months ago benzinga.com
This US Bancorp Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday
This US Bancorp Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday
8 months ago benzinga.com
Nvidia To Rally More Than 53%? Here Are 10 Top Analyst Forecasts For Thursday
Nvidia To Rally More Than 53%? Here Are 10 Top Analyst Forecasts For Thursday
-
8 months ago benzinga.com
Earnings Scheduled For February 24, 2026
Earnings Scheduled For February 24, 2026
8 months ago benzinga.com
FDA Expands Approval For Staar Surgical's Popular Implantable Lens
FDA expands Staar Surgical's EVO ICL approval for ages 21-60, offering a safer, non-LASIK alternative to millions.